Multi-center Study of Myeloablative Allo Stem Cell Transplant for Non-remission AML Using CloBu4 Regimen
Clinical trial NCT01457885 · COMPLETED
Trial details
- NCT number
- NCT01457885
- Sponsor
- University of Michigan Rogel Cancer Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-11-01
- Primary completion
- 2014-11-01
- Enrollment
- 75
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.